Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

RGLS Regulus Therapeutics Inc

1,50

-0,12 (-7,41%)

19 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Regulus Therapeutics Charts.

Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Regulus Therapeutics Charts.

News Regulus Therapeutics Inc

Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences
Dienstag 26 November 2024 (3 Wochen vor) • PR Newswire (US)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Freitag 8 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates
Donnerstag 7 November 2024 (1 Monat vor) • PR Newswire (US)

Form 8-K - Current report
Donnerstag 24 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Freitag 11 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Dienstag 8 Oktober 2024 (2 Monate vor) • PR Newswire (US)

Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences
Mittwoch 28 August 2024 (4 Monate vor) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 8 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 8 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Regulus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Updates
Donnerstag 8 August 2024 (4 Monate vor) • PR Newswire (US)

Weitere Regulus Therapeutics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen